Five years ago, IBM announced that its supercomputer Watson would revolutionize cancer treatment by using its artificial intelligence to digest and distill the thousands of oncology studies published every year plus patient-level data and expert recommendations into treatment recommendation. Last week, a report published by STAT News shows that, years later, IBM’s hubris and hype have crashed into reality.
